Market revenue in 2023 | USD 11,355.7 million |
Market revenue in 2030 | USD 28,950.5 million |
Growth rate | 14.3% (CAGR from 2023 to 2030) |
Largest segment | Chromatography systems |
Fastest growing segment | Filters |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chromatography Systems, Filters, Evaporators, Centrifuges, Dryers |
Key market players worldwide | Merck KGaA, Sartorius AG, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Danaher Corp, Repligen Corp, 3M Co, Boehringer Ingelheim, Corning Inc, Lonza Group Ltd, Dover Corp, Asahi Kasei Corp, Eppendorf |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to downstream processing market will help companies and investors design strategic landscapes.
Chromatography systems was the largest segment with a revenue share of 41.25% in 2023. Horizon Databook has segmented the U.S. downstream processing market based on chromatography systems, filters, evaporators, centrifuges, dryers covering the revenue growth of each sub-segment from 2018 to 2030.
The downstream processing market in the U.S. is expected to grow significantly in the near future owing to increasing adoption of bioprocessing and biotechnology techniques within the country. The commercial production and sale of products that either are obtained from or are used in new biotechnology techniques is relatively recent.
Some of the notable products include Amgen’s Blincyto, a bio-specific antibody approved by FDA in 2018, and Novartis’s Zarxio, the first FDA-approved biosimilar in the U.S. There has been a substantial rise in the sales of biotechnology products within the country owing to the recent advancements and it is expected that there would be a 10-fold increase in the sales in the coming decade. Therefore, continuous innovation in biotechnology sector is expected to provide ample growth opportunities to the U.S. downstream processing market throughout the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. downstream processing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. downstream processing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account